We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5334:TSENiterra Co.,Ltd. Analysis

Data as of 2026-03-11 - not real-time

¥7,907.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Niterra Co., Ltd. is trading well above its 20‑day (≈7,550) and 200‑day (≈5,980) simple moving averages, confirming a bullish price trend despite a recent dip in volume. The RSI of around 63 indicates continued momentum but stays clear of overbought territory, while the MACD histogram is negative and the signal line suggests a short‑term bearish tilt. The current market price of roughly 7,900 JPY sits near the 52‑week high resistance of 8,062 JPY, leaving limited upside and a modest downside cushion. Fundamentally, the company posts an 8.6% revenue growth rate, solid profit margins above 14%, and a respectable ROE of nearly 15%, supporting its Buy consensus among analysts. However, the discounted cash‑flow model values the stock at about 6,700 JPY, implying a ~6% premium that renders the equity slightly overvalued relative to intrinsic estimates. The balance sheet shows a high cash pile offset by sizable debt, resulting in a net‑debt position that warrants monitoring, though the dividend yield of 2.4% and a payout ratio under 40% suggest sustainable shareholder returns. With a low beta of 0.56, the stock exhibits modest market volatility, yet recent 30‑day price swings exceed 38%, reflecting sector‑specific cyclicality. Overall, the blend of strong cash generation, decent valuation multiples, and a resilient dividend profile positions Niterra as a stable, income‑focused holding, while technical signals advise caution near the near‑term resistance level.
Investors should weigh the short‑term bearish cues against the longer‑term fundamentals. The dividend appears sustainable, and the company’s diversified product mix across automotive, semiconductor, and medical ceramics provides a defensive buffer against sector downturns. Given the current market optimism (Extreme Greed sentiment) and the modest overvaluation, a measured approach—holding or modest buying on dips—aligns with the risk‑adjusted upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price approaching 52‑week resistance
  • Bearish MACD signal
  • Decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Solid revenue growth and profit margins
  • Sustainable dividend yield
  • Low market beta indicating stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong free cash flow generation
  • Diversified product portfolio across cyclical and defensive segments
  • Consistent dividend payout and attractive yield

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin14.67%
P/E Ratio16.4
ROE14.80%
ROA7.57%
Debt/Equity40.52
P/B Ratio2.1
Op. Cash Flow¥110.0B
Free Cash Flow¥69.1B

Technical Analysis

TrendBullish
RSI63.0
Support¥6,656.00
Resistance¥8,062.00
MA 20¥7,552.40
MA 50¥7,145.10
MA 200¥5,976.37
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value¥6,692.28
Target Price¥7,403.50
Upside/Downside-6.37%
GradeFair
TypeBlend
Dividend Yield2.41%

Risk Assessment

Beta0.56
Volatility38.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.